View larger
Dengue Virus Subtype 1 Envelope 15kDa, C-Terminal ( Domain III ) Recombinant ( Dengue Envelope-1 15kDa )
DescriptionThe E.coli derived recombinant 12kDa protein is genetically engineered peptide which is derived from Dengue Type-1 envelope III domain immunodeterminant regions. The expressed dengue envelope Type-2 III domain peptide has 100 amino acids
Data sheet
| Storage | Dengue Envelope-ST1 D-III although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles. |
| Formulation | 1x PBS pH 7.4. |
| Purity | Protein is >95% pure as determined by 12% PAGE (coomassie staining). |
| Applications | Each laboratory should determine an optimum working titer for use in its particular application. |
| Description | The E.coli derived recombinant 15kDa protein is genetically engineered peptide which is derived from C terminus of Dengue Type-1 envelope. The expressed protein contains neutralizing epitopes and receptor binding domain, it has been used in the study for vaccine development. A 6 x His Tag is fused at its C-terminus. |
| Protein Background | Caused by one of four closely related virus serotypes of the genus Flavivirus, family Flaviviridae, each serotype is sufficiently different that there is no cross-protection and epidemics caused by multiple serotypes (hyperendemicity) can occur. In cell culture experiments and mice Morpholino antisense oligos have shown specific activity against Dengue virus. |
| Expression host | Escherichia Coli. |